Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma

Overview of attention for article published in Oncogene, April 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 14 X posts from 12 X users, with an upper bound of 32,395 followers.

RT @PancreaticCell: .@LurieCancer scientists including Dr. @LeonidasPlatan1 suggest an essential role for SLFN5 in #PDAC. Abstract in @onc…

RT @PancreaticCell: .@LurieCancer scientists including Dr. @LeonidasPlatan1 suggest an essential role for SLFN5 in #PDAC. Abstract in @onc…

RT @oncogenejournal: In their latest and exciting study @LeonidasPlatan1 & co-workers identify a novel role of SLFN5 in pancreatic cancer -…

RT @LeonidasPlatan1: Here is a paper we just published, suggesting a potentially new therapeutic target for pancreatic adenocarcinoma.…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.